Biothus - Web3 Crypto Company Profile, Funding, Valuation, Investors - Cointime

Bitcoin $88,066.89 -3.21%
Ethereum $3,060.04 -4.76%
BNB $618.29 -4.62%
Optimism $1.53 -8.46%
Arbitrum $0.58 -6.58%
Solana $210.64 -3.96%
Polygon $0.36 -4.62%
Cosmos $5.02 -3.69%
Avalanche $31.96 -4.66%

Bitcoin $88,066.89 -3.21%
Ethereum $3,060.04 -4.76%
BNB $618.29 -4.62%
Optimism $1.53 -8.46%
Arbitrum $0.58 -6.58%
Solana $210.64 -3.96%
Polygon $0.36 -4.62%
Cosmos $5.02 -3.69%
Avalanche $31.96 -4.66%

Biothus

company

Summary
Funding Rounds
Investors

About

Biothus is a pharmaceutical company, focused on antibody-based drugs

11 - 50

Highlights

Total Funding Amount

Details

Last Funding Type: Series A
Last Funding Money Raised: ¥180M
Industries: Biotechnology,Health Care
Founded date: Feb 1, 2018
Number Of Employee: 11 - 50
Operating Status: Active

Funding Rounds

Number of Funding Rounds

Total Funding Amount

1

¥180M

Biothus has raised a total of ¥180M in funding over 2 rounds. Their latest funding was raised on Oct 30, 2018 from a Series A round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Oct 30, 2018	Series A	¥180M	1	Zhuhai Huajin Asset	—	Detail

Investors

Number of Lead Investors

Number of Investors

1

1

Biothus is funded by 1 investors. Zhuhai Huajin Asset are the most recent investors.

Investor Name	Lead Investor	Funding Round
Zhuhai Huajin Asset	Yes	Series A